New injection targets arthritis flares in early trial
NCT ID NCT07245992
First seen Dec 08, 2025 · Last updated May 16, 2026 · Updated 20 times
Summary
This early-stage study tests a new drug called F8IL10 for people with rheumatoid arthritis. The drug is injected directly into an inflamed joint to see if it is safe and to find the best dose. About 42 adults with arthritis flares will take part. The goal is to measure side effects and how well the body tolerates the treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS (RA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arcispedale Santa Maria Nuova
NOT_YET_RECRUITINGReggio Emilia, Reggio Emilia, 42123, Italy
Contact
-
Azienda Ospedaliera Universitaria Integrata Verona c/o Policlinico GB Rossi (Borgo Roma), Dep. Reumatologia
RECRUITINGVerona, VR, 37134, Italy
Contact
Conditions
Explore the condition pages connected to this study.